Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Free Cash Flow: 2019-2024

Historic Free Cash Flow for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to -$110.1 million.

  • P3 Health Partners' Free Cash Flow rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.7 million, marking a year-over-year decrease of 7904.92%. This contributed to the annual value of -$110.1 million for FY2024, which is 4145.27% down from last year.
  • Per P3 Health Partners' latest filing, its Free Cash Flow stood at -$110.1 million for FY2024, which was down 4145.27% from -$77.9 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Free Cash Flow registered a high of -$27.5 million during FY2020, and its lowest value of -$128.3 million during FY2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$77.9 million (2023), whereas its average is -$79.6 million.
  • As far as peak fluctuations go, P3 Health Partners' Free Cash Flow skyrocketed by 3929.53% in 2023, and later crashed by 4145.27% in 2024.
  • Over the past 5 years, P3 Health Partners' Free Cash Flow (Annual) stood at -$27.5 million in 2020, then tumbled by 97.73% to -$54.4 million in 2021, then crashed by 135.68% to -$128.3 million in 2022, then surged by 39.3% to -$77.9 million in 2023, then tumbled by 41.45% to -$110.1 million in 2024.
  • Its last three reported values are -$110.1 million in FY2024, -$77.9 million for FY2023, and -$128.3 million during FY2022.